Amgen Earnings Reaction Close To All-Time Highs!
Read the original article at 24/7 Wall St.
July 26, 2012 By Leave a Comment
Amgen Inc. (NASDAQ: AMGN) today announced financial results for the second quarter of 2012. The biotech giant’s results showed a 13% revenue gain to $4.5 billion and adjusted earnings rose 34%...
Read the original article at 24/7 Wall St. 